DeepMed Research

University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Effects of Quitting Study A Test of Pre-clinical Findings

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: Smokers cease smoking

First Posted Date: 2013-04-04

Last Posted Date: 2016-03-14

Lead Sponsor: University of Vermont

Target Recruit Count: 287

Registration Number: NCT01824511

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States
🇺🇸
Dartmouth College, Hanover, New Hampshire, United States

Treating Cocaine Abuse: A Behavioral Approach

Phase 2

Conditions: Cocaine Dependence

Interventions: Behavioral: Contingency Management

First Posted Date: 2013-04-02

Last Posted Date: 2013-04-02

Lead Sponsor: University of Vermont

Target Recruit Count: 124

Registration Number: NCT01822327

Locations: 🇺🇸
Substance Abuse Treatment Center, University of Vermont; UHC, Burlington, Vermont, United States

Treatment of Smoking Lapses and Relapses

Phase 4

Completed

Conditions: Smoking Cessation

Interventions: Drug: nicotine patch, experimental use
Drug: nicotine patch, labeled use

First Posted Date: 2013-03-08

Last Posted Date: 2017-10-13

Lead Sponsor: University of Vermont

Target Recruit Count: 701

Registration Number: NCT01807871

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Voucher Based Incentives to Treat Pregnant Smokers

Not Applicable

Completed

Conditions: Efficacy of Financial Incentives

Interventions: Behavioral: Voucher-based incentives

First Posted Date: 2013-02-28

Last Posted Date: 2023-05-12

Lead Sponsor: University of Vermont

Target Recruit Count: 166

Registration Number: NCT01801384

Locations: 🇺🇸
Substance Abuse Treatment Center, University of Vermont; UHC, Burlington, Vermont, United States

Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study

Not Applicable

Conditions: Chronic Pain

Interventions: Behavioral: Therapeutic Interactive Voice Response
Behavioral: NO TIVR
Behavioral: Group Cognitive Behavioral Therapy
Behavioral: Pain Education

First Posted Date: 2013-02-20

Last Posted Date: 2013-02-20

Lead Sponsor: University of Vermont

Target Recruit Count: 120

Registration Number: NCT01794988

Locations: 🇺🇸
University of Vermont College of Medicine, MindBody Medicine Clinic, Burlington, Vermont, United States

Platelet Reactivity After CABG

Completed

Conditions: Acute Coronary Syndrome

First Posted Date: 2013-02-15

Last Posted Date: 2015-09-22

Lead Sponsor: University of Vermont

Target Recruit Count: 18

Registration Number: NCT01793597

Locations: 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

Branched Chain Amino Acid Plus Glucose Supplement Reduces Exercise-Induced Delayed Onset Muscle Soreness in College Females

Not Applicable

Completed

Conditions: Exercise-induced Delayed Onset Muscle Soreness

Interventions: Dietary Supplement: Branched Chain Amino Acid drink supplement
Dietary Supplement: Placebo

First Posted Date: 2013-02-01

Last Posted Date: 2013-02-01

Lead Sponsor: University of Vermont

Target Recruit Count: 20

Registration Number: NCT01781910

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

An Internet-based Weight Loss and Exercise Intervention for Breast Cancer Survivors

Not Applicable

Conditions: Breast Cancer

Interventions: Behavioral: Weight Loss and Exercise

First Posted Date: 2012-11-19

Last Posted Date: 2015-05-18

Lead Sponsor: University of Vermont

Target Recruit Count: 48

Registration Number: NCT01728506

Locations: 🇺🇸
University of Massachusetts, Worcester, Massachusetts, United States
🇺🇸
Dartmouth Hitchcock Medical Center, Hannover, New Hampshire, United States
🇺🇸
Unviersity of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States

Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma

Phase 1

Completed

Conditions: Stage III Adult Soft Tissue Sarcoma

Interventions: Drug: Gemcitabine
Drug: Docetaxel
Drug: Pazopanib

First Posted Date: 2012-11-01

Last Posted Date: 2016-06-16

Lead Sponsor: University of Vermont

Target Recruit Count: 6

Registration Number: NCT01719302

Locations: 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States

Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence

Not Applicable

Completed

Conditions: Major Depressive Disorder, Recurrent, With Seasonal Pattern
Seasonal Affective Disorder (SAD)
Winter Depression

Interventions: Behavioral: Cognitive-Behavioral Therapy (CBT)
Device: Light Therapy (LT)

First Posted Date: 2012-10-25

Last Posted Date: 2023-05-09

Lead Sponsor: University of Vermont

Target Recruit Count: 177

Registration Number: NCT01714050

Locations: 🇺🇸
University of Vermont, Psychology Department, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy